Article
Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Medicine - 26 Jan 2024
Zhang Murui, Hu Xiaotong, Liu Lunming, Wang Yihong, Jiang Junchang, Li Hui, Fei Weiqiang, Zhong Tingting, Jiang Zhinong
Abstract excerpt
BACKGROUND: The newly released 2022 WHO Classification of Neuroendocrine Neoplasms (version 5) and a recent update on thyroid tumor classifications have emphasized genetic testing to an unprecedented level. Fine needle aspiration (FNA) has been widely applied for the preoperative diagnosis of thyroid nodules. However, it is limited mainly to testing for a single gene-BRAFV600E, whereas multi-gene testing data are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
